Previous 10 | Next 10 |
Hologic ( HOLX +0.1% ) is up modestly on below-average volume on the heels of the publication of performance characteristics of its SARS-CoV-2 molecular test performed on its automated Panther system. More news on: Hologic, Inc., Healthcare stocks news, Stocks on the move, Read mor...
Latest innovation expands portfolio of ultrasound technologies with premium offering designed to enhance efficiency and accuracy Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of the SuperSonic™ MACH 40 ultrasound system, expanding the Company’s suite of ult...
This article was highlighted for PRO subscribers, Seeking Alpha’s service for professional investors. Find out how you can get the best content on Seeking Alpha here . Executive Summary and Investment Conclusion After multiple years of negative earnings revisions and a stagnant r...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2020 on Wednesday, July 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time....
As of June 18, the number of COVID-19 cases in the United States had ballooned to over 2.2 million. More than 117,000 of those patients have died -- more than a quarter of the pandemic's global death toll. Now, with the Trump administration intensifying its push to revive economic activity ...
Quick Take Genetron Holdings ( GTH ) has filed to raise $162.5 million in an IPO of ADSs representing underlying ordinary shares, according to an amended registration statement . The company provides a range of cancer diagnostic and research services in China. GTH is positioned in a gro...
In a regulatory filing, Hologic (NASDAQ: HOLX ) says that its financial outlook for FQ3 has improved since April 29. More news on: Hologic, Inc., Healthcare stocks news, , Read more ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming virtual investor conferences: The Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9 at 10:30 a.m. Eastern Time (ET). The William Blair 40ᵗʰ Annual Growt...
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 05/15/2020. Please visit our Tracking Larry Robbins’ Glenview Capital Manage...
Hologic (NASDAQ: HOLX) , after earning an emergency use authorization (EUA) for a second COVID-19 molecular test from the Food and Drug Administration on May 15, is trading just a few dollars off its all-time high of $55.25, set on Feb. 4. The question for the Marlborough, Mass. medical ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...